The mission of Nanothermia, or modulated electro-hyperthermia (mEHT), is to heal cancer, increase life expectancy and improve the quality of life of the patients with cancer. Modulated electro-hyperthermia (mEHT) is a complementary antitumor therapy applying capacitive radiofrequency at 13.56 MHz. It is a personalized, non-toxic therapy using an electric field and promoting the body’s natural regulatory processes.
Unlike conventional HT, however, mEHT does more than simply warm deep layers of tissue or function solely via certain thermodynamic parameters like temperature, it also combines such warming with a modulated electric field, generated by two active electrodes. Micro-biological tests have proven that malignant tissue has higher conductivity than healthy human tissue.